My Account | Shopping Cart | Contact
Trilink Biotech Logo

Oligonucleotides | mRNA & Long RNA | Nucleotides | CleanCap™ | CleanTag™ | CleanAmp™ | Custom Chemistry | GMP

OligoBuilder® | Nucleotides List | Stocked mRNA List | DNA Synthesis Reagents List | CleanAmp™ Products List


You are at: All > Nucleotides > Nucleotides by Structural Class > Base Modified Ribonucleoside Triphosphates

N-1014
5-Methylcytidine-5'-Triphosphate
5-Methyl-CTP, 5-Me-CTP, 5mCTP, 5-mCTP

5-Methylcytidine-5'-Triphosphate

Extinction Coefficient: 7,808 Lmol-1cm-1 at 279 nm
Molecular Weight: 497.1 g/mol (free acid)
Molecular Formula:  : C10H18N3O14P(free acid)
Salt Form: Lithium
Purity Specification: ≥95% by AX-HPLC 

Shipped at 100 mM in H2O.
1 µmole: 10 µL
5 µmole: 50 µL
10 µmole: 100 µL


Purchase with Pseudo-UTP and ARCA, save 10%!
 

Certificate(s) of Analysis

 
RNA methylation signals a plethora of cellular functions including biochemical and metabolic stabilization of RNA, immune response, resistance to antibiotics, mRNA reading frame maintenance, splicing and more. Methylation of the 5 position of cytidine is a common, post-transcriptional modification in a number of RNA species, such as mRNA, miRNA and tRNA. 5-Methylcytidine-5'-Triphosphate (5-Methyl-CTP) is a modified nucleoside triphosphate employed to impart desirable characteristics such as increased nuclease stability, increased translation or reduced interaction of innate immune receptors with in vitro transcribed RNA. 5-Methyl-CTP, as well as Pseudo-UTP and 2-Thio-UTP, have been shown to reduce innate immune stimulation in culture and in vivo while enhancing translation in recent publications by Kormann et al. and Warren et al.
 
Kormann et al. demonstrated the improvement of therapeutic mRNA in vivo delivery by chemical modification. Chemical modifications explored included Pseudo-U, N6-Methyl-A, 2-Thio-U and 5-Methyl-C. The team found that by substituting 25% of the uridine and cytidine with 2-Thio-U and 5-Methyl-C respectively, they were able to significantly decrease toll-like receptor (TLR) mediated recognition of the mRNA in mice. By reducing the activation of the innate immune system, these modifications also increase the stability and longevity of the mRNA in vivo.

Warren et al. determined an efficient means of reprogramming multiple human cell types using modified mRNA that can express the four primary reprogramming proteins. These cells are referred to as induced pluripotency stem cells (iPSCs). Warren et al. found that enzymatically synthesized RNA employing 5-Methyl-CTP, Pseudo-UTP and ARCA effectively evaded the cell’s antiviral response, a crucial component in their success.This reduced toxicity associated with repeated transfection with in vitro transcribed mRNA.




Email a Friend
Product Inquiry
    
Ready To Order?

Please select a size :
   1 µmole ($91.00)
   5 µmoles ($425.00)
   10 µmoles ($728.00)


 



Related Products :

Related Categories :


Reference(s)
Wroblewska L, Kitada T, Endo K, Siciliano V, Stillo B, Saito H, Weiss R.Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery.Nat Biotechnol. 2015 Aug
Pratico ED, Feger BJ, Watson MJ, Sullenger BA, Bowles DE, Milano CA, Nair SK.RNA-Mediated Reprogramming of Primary Adult Human Dermal Fibroblasts into c-kit+ Cardiac Progenitor Cells.Stem Cells Dev. 2015 Aug 13.
Abraham MK, Nolte A, Reus R, Behring A, Zengerle D,et al.In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.PLoS One. 2015 Sep
Baba M, Itaka K, Kondo K, Yamasoba T, Kataoka K. Treatment of neurological disorders by introducing mRNA in vivo using polyplex nanomicelles.J Control Release. 2015 Jan 17;201C:41-48. doi: 10.1016/j.jconrel.2015.01.017
Huang CL, Leblond AL, Turner EC, Kumar AH, Martin K, Whelan D, O'Sullivan DM, Caplice NM. Synthetic Chemically Modified mRNA-Based Delivery of Cytoprotective Factor Promotes Early Cardiomyocyte Survival Post-Acute Myocardial Infarction.Mol Pharm 2015 Jan
Andries O,Mc Cafferty S,et al.N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice.J Control Release. 2015 Sep 3
Hausburg F, Na S, Voronina N, Skorska A, Müller P, Steinhoff G, David R. Defining Optimized Properties of Modified mRNA to Enhance Virus- and DNA- Independent Protein Expression in Adult Stem Cells and Fibroblasts. Cell Physiol Biochem. 2015 Feb 12
Lee K, Yu P, Lingampalli N, Kim HJ, Tang R, Murthy N.Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells.Int J Nanomedicine. 2015 Mar 6
Guo XR, et al. PDX-1 mRNA-induced reprogramming of mouse pancreas-derived mesenchymal stem cells into insulin-producing cells in vitro. Clin Exp Med. 2014 Oct 28.
Wang Xiao, et al. Reprogramming human umbilical cord mesenchymal stromal cells to islet-like cells with the use of in vitro–synthesized pancreatic-duodenal homebox 1 messenger RNA. Volume 16, Issue 11, November 2014, Pages 1519–1527
Wang Y, Su HH, Yang Y, Hu Y, Zhang L, Blancafort P, Huang L. Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy. Mol Ther. 2013 Feb;21(2):358-67.
Uchida S, Itaka K, Uchida H, Hayakawa K, Ogata T, Ishii T, Fukushima S, Osada K, Kataoka K. In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle. PLoS One. 2013;8(2):e56220.
Hernandez LI, Flenker KS, Hernandez FJ, Klingelhutz AJ, McNamara JO, Giangrande PH. Methods for Evaluating Cell-Specific, Cell-Internalizing RNA Aptamers. Pharmaceuticals. 2013; 6(3):295-319.
Mandal PK, Rossi DJ. Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat Protoc. 2013 Feb 21;8(3):568-82.
Pardi N, Muramatsu H, Weissman D, Karikó K. In vitro transcription of long RNA containing modified nucleosides. Methods Mol Biol. 2013;969:29-42. doi: 10.1007/978-1-62703-260-5_2.
Loh YH, Yang JC, Angeles Ade L, Guo C, Cherry A, Rossi DJ, Park IH, Daley GQ. Excision of a viral reprogramming cassette by delivery of synthetic cre mRNA. Curr Protoc Stem Cell Biol. 2012 May;Chapter 4:Unit4A.5.
Warren L, Ni Y, Wang J, Guo X. Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci Rep. 2012;2:657.
Motorin Y, Helm M. RNA nucleotide methylation. Wiley Interdiscip Rev RNA. 2011 Sep-Oct;2(5):611-31.
Kormann M, Hasenpusch G, Aneja M, et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. (2011) Nature Biotechnology 29:154–157.
Kariko K, Muramatsu H, Ludwig J, Weissman D. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein encoding mRNA. (2011) Nucleic Acids Research.
Anderson, B., Muramatsu, H., Nallagatla, S.R., Bevilacqua, P.C., Sansing, L.H., Weissman, D. & Kariko, K. Incorporation of pseudouridine into mRNA enhances translation by dimishing PKR activation (2010) Nucleic Acids Research, 38(17): 5884-5892.
Warren et al., Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA, Cell Stem Cell (2010), doi:10.1016/j.stem.2010.08.012.
Kariko K, Muramatsu H, Welsh F, et al. Incorporation of Pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. (2008) Molecular Therapy (16)11: 1833-1840.
Kariko, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modifiation and the Evolutionary Origin of RNA (2005). Immunity, 23(2), 165-175.
Lefmann M, et al. Novel Mass Spectrometry-based tool for genotypic identification of mycobacteria. (2004) Journal of Clinical Microbiology, 42(1): 339-346.
Hartmer R, Storm N, Boecker S, Rodi CP, Hillenkamp F, Jurinke C, van den Boom D. RNase T1 mediated base-specific cleavage and MALDI-TOF MS for high-throughput comparative sequence analysis. (2003) Nucleic Acids Res., 31(9): e47.
Nguyen A, Zhao C, Dorris D, Mazumder A. Quantitative assessment of the use of modified nucleoside triphosphates in expression profiling: differential effects on signal intensities and impacts on expression ratios. (2002) BMC Biotechnology, 2(1): 14.
Van Rompay AR, Norda A, Linden K, Johansson M, Karlsson A. Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. (2001) Mol Pharmacol., 59(5): 1181-6.


 

 


  Twitter Twitter Facebook Facebook Linked In Linked In RSS RSS Google RSS  
© 2017 TriLink BioTechnologies, LLC | All Rights Reserved